Skip to main content Help with accessibility Skip to main navigation

BROLUCIZUMAB solution for injection (Beovu®▼) for treating wet age-related macular degeneration

CCG Approval Status:

Date Added: 24 - Feb - 2021
Body System:
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of BROLUCIZUMAB solution for injection (Beovu®▼), by specialists only for treating wet age-related macular degeneration in line with NICE TA672.